The oversight board is overturning a decision to leave up paid material promoting ketamine.
In a decision shared first with The Technology 202, the panel wrote that the material, posted by a verified user with over 200,000 followers who was paid by a major ketamine provider, violated Meta’s rules for branded content, which set limits on posts promoting restricted or illicit drugs.
“This case indicates that Meta’s strong restrictions on branded content promoting drugs and attempts to buy, sell, or trade drugs may be inconsistently enforced,” the group wrote. The post, which was viewed roughly 85,000 times, described using the drug to treat depression as a “medical entry into another dimension” but provided no “professional diagnosis” or information “showing the treatment took place under medical supervision,” the board wrote.
Meta, Instagram’s parent company, said in a statement to The Technology 202 that it would remove the content within a week and review the board’s recommendations. by the Wall Street Journal finding that “telehealth companies are flooding TikTok, Instagram and other platforms with ads that don’t conform to longtime standards governing the marketing of prescription drugs and healthcare treatments.”
The report uncovered numerous instances of companies promoting the “psychiatric benefits of ketamine even though the FDA issued a warning in February that the drug isn’t approved for the treatment of any psychiatric disorder.” In total, the report found “at least 800 ads promoting controlled substances” on social media over a four-week period last year.
Lawmakers have separately floated rolling back tech companies’ legal protections under Section 230 if they did not take added steps to curb drug sales or promotion on their sites, such asAs part of its ruling, the oversight board also urged the tech giant to change its policies to make its restrictions around branded content more clear.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Opinion | Regulators Gone WildThe White House is rewriting the rules for cost-benefit analysis to unleash its regulators.
Read more »
Linera Blockchain Raises Additional $6M for Innovative Microchain Design Evolving from Meta’s Novi ResearchLinera reaches a total of $12M in seed funding. The new round of funding was led by Borderless Capital with contributions from a16z crypto, Laser Digital
Read more »
Analysis | Cyber experts say regulators aren't going far enough with their rulesAround 49 percent of experts who responded to a Cybersecurity 202 survey said cyber regulators aren’t going far enough.
Read more »
ANALYSIS: China Turns to Well-Honed Playbook: Cut Rates, Hide DataChina’s authorities responded to another burst of dire news on the economy with a well-honed playbook: They cut interest rates and withheld som...
Read more »
ANALYSIS: ‘Ruzzki not welcome’: the Russian exiles getting a hostile reception in GeorgiaAfter the invasion of Ukraine, thousands of Russians fled to Tbilisi. But the graffiti that has sprung up across the city suggests not everyone is ...
Read more »
ANALYSIS: In Ohio, civic bridges over cultural dividesSince the U.S. Supreme Court rescinded constitutional protection of abortion a year ago, every state ballot measure affirming the right of women to...
Read more »